These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9484644)

  • 21. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
    Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
    Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic cytology of serous effusions (author's transl)].
    Djelali D
    Ther Umsch; 1973 Aug; 30(8):611-7. PubMed ID: 4751584
    [No Abstract]   [Full Text] [Related]  

  • 23. Ber-EP4 staining in effusion cytology: A potential source of false positives.
    Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ
    Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
    Ang PP; Tan GC; Karim N; Wong YP
    Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 immunostaining is a highly specific and moderately sensitive marker of malignancy in serous fluid cytology.
    Mayall F; Heryet A; Manga D; Kriegeskotten A
    Cytopathology; 1997 Feb; 8(1):9-12. PubMed ID: 9068950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of three commonly used cytologic preparations in effusion immunocytochemistry.
    Fetsch PA; Simsir A; Brosky K; Abati A
    Diagn Cytopathol; 2002 Jan; 26(1):61-6. PubMed ID: 11782091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
    Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
    Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of cell blocks to assist in precise cytological diagnosis of serous effusion].
    Sun MJ; Liu LT; Li CY; Liu DG; Chen L
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):830-836. PubMed ID: 39103265
    [No Abstract]   [Full Text] [Related]  

  • 30. Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions.
    Rehnberg J; Zendehrokh N; Dejmek A
    Anal Quant Cytol Histol; 2007 Aug; 29(4):217-20. PubMed ID: 17879629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytologic and Immunophenotypic Features of Malignant Cells in Pediatric Body Fluids.
    Ahmed AA; Andraws N; Almutairi AM; Saied HM; Elbagir-Mohamed AM
    Acta Cytol; 2015; 59(4):332-8. PubMed ID: 26422236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytology and flow cytometry of malignant effusions of multiple myeloma.
    Palmer HE; Wilson CS; Bardales RH
    Diagn Cytopathol; 2000 Mar; 22(3):147-51. PubMed ID: 10679993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaplastic large cell lymphoma diagnosed from ascitic and pleural fluid effusion cytology in a paediatric patient.
    Stephen N; Ravi S; Balakrishnan K; Siddaraju N; Basu D; Gochhait D; Ganesan P
    Cytopathology; 2020 Jul; 31(4):321-324. PubMed ID: 32369653
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytomorphologic features of metastatic urothelial carcinoma in serous effusions.
    Huang CC; Attele A; Michael CW
    Diagn Cytopathol; 2013 Jul; 41(7):569-74. PubMed ID: 22833290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis.
    Gupta P; Pandey T; Gautam U; Rajwanshi A; Srinivasan R; Gupta N; Rohilla M; Varma N; Dey P
    Diagn Cytopathol; 2021 May; 49(5):647-656. PubMed ID: 33629825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assaying of tumor necrosis factor alpha, complement factors, and alpha-1-antitrypsin in the diagnosis of malignant serous effusions.
    Alexandrakis MG; Kyriakou D; Koutroubakis IE; Alexandraki R; Vlachonikolis IG; Eliopoulos GD
    Am J Clin Oncol; 2001 Dec; 24(6):562-5. PubMed ID: 11801754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
    Kundu R; Handa U; Mohan H
    Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytological features of lung adenocarcinoma with micropapillary pattern in the pleural or pericardial effusion: analysis of 5 cases.
    Ishida M; Kagotani A; Iwai M
    Int J Clin Exp Pathol; 2014; 7(8):5111-6. PubMed ID: 25197384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytology of body cavity fluids - established methods and new developments].
    Engels M
    Pathologe; 2022 Mar; 43(2):91-98. PubMed ID: 34994855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical staining of serous effusions: an additional method in the routine cytology practice?
    Lidang Jensen M; Johansen P
    Cytopathology; 1994 Apr; 5(2):93-103. PubMed ID: 8038428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.